O99.32 Drug use complicating pregnancy, childbirth, and the puerperium

Name of the Condition

• Drug use complicating pregnancy, childbirth, and the puerperium

Summary

This condition describes complications arising from drug use during pregnancy, labor, delivery, or the postpartum period (puerperium). It affects both maternal and fetal health, with risks extending beyond pregnancy into the early postpartum phase.

Causes

The condition is caused by the use of substances—including illicit drugs, prescription medications, or over-the-counter drugs—during pregnancy, childbirth, or the puerperium. These substances can cross the placenta or affect maternal physiology, leading to adverse outcomes.

Risk Factors

• History of substance use or addiction
• Inadequate prenatal or postpartum care
• Mental health conditions (e.g., depression, anxiety)
• Socioeconomic stressors or lack of support systems
• Prior complications from drug use in pregnancy

Symptoms

• Maternal: Withdrawal symptoms, overdose, or altered mental status
• Fetal/Neonatal: Growth restriction, congenital anomalies, or withdrawal symptoms
• Labor/Delivery: Preterm labor, placental abruption, or fetal distress
• Postpartum: Maternal infection, poor wound healing, or substance-related complications

Diagnosis

Diagnosis involves a comprehensive maternal history, substance use screening (e.g., urine or blood tests), and clinical evaluation. Prenatal or postpartum assessments may include fetal monitoring, ultrasound, or neonatal testing to detect effects on the fetus or newborn.

Treatment Options

• Cessation of harmful substances with medical supervision
• Detoxification or addiction counseling
• Prenatal or postpartum care to monitor maternal and fetal/neonatal health
• Management of withdrawal symptoms or overdose
• Supportive care (e.g., nutrition, mental health services)

Prognosis and Follow-Up

Prognosis depends on the substance, timing, and duration of use, as well as access to care. Close follow-up is essential to monitor maternal recovery, fetal development (if applicable), and neonatal health. Long-term outcomes may include developmental delays or chronic health issues.

Complications

• Maternal: Overdose, infection, or mental health crises
• Fetal/Neonatal: Low birth weight, preterm birth, or neonatal abstinence syndrome
• Labor/Delivery: Placental abruption, stillbirth, or maternal hemorrhage
• Postpartum: Poor bonding, maternal relapse, or infant neglect

Lifestyle & Prevention

• Avoid non-prescribed drugs during pregnancy and postpartum
• Use prescribed medications only as directed by a healthcare provider
• Seek prenatal care early and disclose substance use to providers
• Engage in support groups or counseling for substance use disorders
• Maintain a stable, low-stress environment postpartum

When to Seek Professional Help

• Unexplained maternal symptoms (e.g., dizziness, confusion)
• Fetal movement changes or reduced activity
• Signs of withdrawal (e.g., tremors, irritability) in the mother or newborn
• Persistent substance cravings or relapse risk
• Concerns about maternal or infant health during pregnancy or postpartum

Tips for Medical Coders

Document the specific substance(s) involved, timing (pregnancy, childbirth, or puerperium), and any associated complications. Ensure clear differentiation between prescribed and non-prescribed drug use. Code O99.32 is appropriate when drug use complicates pregnancy, childbirth, or the puerperium, with additional codes for specific substances or trimesters if documented.